Inventor · disambiguated record
Bin Zhu
Also filed as: ZHU BIN
32 granted patents·9 pending applications·441 citations·filing 2002–2021
97Inventor score
Files withJANSSEN PHARMACEUTICA NV21BIAN HAIYAN5COLBURN RAYMOND W3CONNOLLY PETER J2MERCK SHARP & DOHME2
Top patents by PatentIndex Score
41 records- 0198US8426401B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Apr 23, 2013·77 cites·18 claims
- 0297US8759333B2Di-azetidinyl diamide as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 24, 2014·45 cites·2 claims
- 0397US8741887B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jun 3, 2014·49 cites·4 claims
- 0497US8697684B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·48 cites·4 claims
- 0597US8604017B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Dec 10, 2013·49 cites·4 claims
- 0697US8399454B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Mar 19, 2013·53 cites·17 claims
- 0792US8685990B2Pyrimidine compounds as delta opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 1, 2014·19 cites·3 claims
- 0890US8367653B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Feb 5, 2013·8 cites·19 claims
- 0988US8362000B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 29, 2013·6 cites·17 claims
- 1088US8324217B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2012·Granted Dec 4, 2012·13 cites·11 claims
- 1188US8143259B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2009·Granted Mar 27, 2012·13 cites·24 claims
- 1286US8653099B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2009·Granted Feb 18, 2014·9 cites·27 claims
- 1386US8455476B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Jun 4, 2013·5 cites·30 claims
- 1486US8415341B2Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitorsCHEVALIER KRISTEN·Filed 2010·Granted Apr 9, 2013·18 cites·18 claims
- 1585US8362001B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 29, 2013·4 cites·18 claims
- 1684US8445477B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted May 21, 2013·4 cites·20 claims
- 1783US8450303B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted May 28, 2013·3 cites·17 claims
- 1881US8722658B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 13, 2014·2 cites·4 claims
- 1981US8697683B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·2 cites·4 claims
- 2081US8623858B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jan 7, 2014·2 cites·4 claims
- 2180US8962607B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Feb 24, 2015·2 cites·9 claims
- 2280US8691805B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 8, 2014·2 cites·8 claims
- 2373US10118900B2Benzimidazole derivatives useful as CB-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Nov 6, 2018·1 cites·14 claims
- 2472US8759533B2Di-azetidinyl diamide as monoacylglcerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 24, 2014·1 cites·12 claims
- 2572US8637498B2Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitorsCONNOLLY PETER J·Filed 2011·Granted Jan 28, 2014·2 cites·30 claims
- 2667US7041661B2Use of thiazolobenzoheterocycles for treating multiple sclerosisAVENTIS PHARMA INC·Filed 2003·Granted May 9, 2006·2 cites·7 claims
- 2766US6825172B23-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agentsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Nov 30, 2004·2 cites·22 claims
- 2862US2023295157A13-(1h-imidazol-2-yl)-2,3,8,8a-tetrahydroindolizin-5(1h)-one derivatives useful as factor xia inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2958US2019031618A1Benzimidazole derivatives useful as cb-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 3057US9096521B2Cold menthol receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 4, 2015·0 cites·21 claims
- 3156US2024109917A1Pyrazolothiazole carboxamides and their uses as pdgfr inhibitorsACTELION PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 3252US2009270379A1Quinolone derivatives useful as antibacterial agentsMACIELAG MARK J·Filed 2009·Application pending·0 cites
- 3352US2009156577A17-amino alkylidenyl-heterocyclic quinolones and naphthyridonesDAVIS BENJAMIN·Filed 2008·Application pending·0 cites
- 3451US2012058986A1Di-azetidinyl diamide as monoacylglycerol lipase inhibitorsCONNOLLY PETER J·Filed 2011·Application pending·0 cites
- 3546US2021253562A1Acylsufonamide compounds useful as ep3 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 3645US8513271B2Pyrimidine compounds as delta opioid receptor modulatorsCOATS STEVEN J·Filed 2010·Granted Aug 20, 2013·0 cites·25 claims
- 3742US11655216B2Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted May 23, 2023·0 cites·8 claims
- 3842US2005250713A111,12-Cyclic thiocarbamate macrolide antibacterial agentsZHU BIN·Filed 2005·Application pending·0 cites
- 3941US8815839B2Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Aug 26, 2014·0 cites·11 claims
- 4039US10894775B2Piperidine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Jan 19, 2021·0 cites·12 claims
- 4136US2003154499A1Mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a VLA-4 receptorFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bin Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →